Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guideline – Pancreatic Cancer

Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Ann Oncol. 2023;34(11):987-1002.

Conroy T, Pfieiffer P, Vilgrain V, et al., on behalf of the ESMO Guidelines Committee

  • The guideline covers diagnosis, staging, risk assessment, treatment, disease monitoring and follow-up.
  • The multidisciplinary expert author group is from different institutions and countries in Europe, Asia and the USA.
  • Recommendations are based on available scientific data and the authors’ collective expert opinion.
  • ESMO-MCBS and ESCAT scores provide levels of evidence for treatment choices, including targeted therapies.
  • In clinical practice, all recommendations provided need to be discussed with patients in a shared decision-making approach.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.